GTAM
COCP icon

Global Trust Asset Management’s Cocrystal Pharma COCP Stock Holding History

Global Trust Asset Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-83
Closed -$1K – 412
2021
Q1 		$1K Buy
+83
New +$1.69K ﹤0.01% 359

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Global Trust Asset Management's COCP Position: Q2 2021 in Review

Global Trust Asset Management sold out of Cocrystal Pharma (COCP) in Q2 2021, closing a stake of 83 shares — an estimated $1K sold.

Global Trust Asset Management first reported a position in COCP in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 42 funds tracked by Wall St. Rank hold COCP as of Q2 2021.

  • Global Trust Asset Management reported no remaining Cocrystal Pharma position as of Q2 2021 after selling out during the quarter.
  • Global Trust Asset Management sold 83 Cocrystal Pharma shares in Q2 2021, an estimated $1K.
  • Global Trust Asset Management first reported a position in Cocrystal Pharma in Q1 2021 and held it in 1 quarter.
  • Global Trust Asset Management's Cocrystal Pharma position peaked at $1K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2021.

Based on Global Trust Asset Management's 13F filing for Q2 2021, filed 13 Jul 2021.